|
1
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zlotnik A and Yoshie O: Chemokines: a new
classification system and their role in immunity. Immunity.
12:121–127. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ben-Baruch A: Site-specific metastasis
formation: chemokines as regulators of tumor cell adhesion,
motility and invasion. Cell Adh Migr. 3:328–333. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen G, Chen SM, Wang X, Ding XF, Ding J
and Meng LH: Inhibition of chemokine (CXC motif) ligand
12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated
cell migration by targeting mammalian target of rapamycin (mTOR)
pathway in human gastric carcinoma cells. J Biol Chem.
287:12132–12141. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nannuru KC, Sharma B, Varney ML and Singh
RK: Role of chemokine receptor CXCR2 expression in mammary tumor
growth, angiogenesis and metastasis. J Carcinog. 10:402011.
View Article : Google Scholar
|
|
7
|
Hao M, Zheng J, Hou K, et al: Role of
chemokine receptor CXCR7 in bladder cancer progression. Biochem
Pharmacol. 84:204–214. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee YS, Choi I, Ning Y, et al:
Interleukin-8 and its receptor CXCR2 in the tumour microenvironment
promote colon cancer growth, progression and metastasis. Br J
Cancer. 106:1833–1841. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu FY, Zhao ZJ, Li P, et al: NF-κB
participates in chemokine receptor 7-mediated cell survival in
metastatic squamous cell carcinoma of the head and neck. Oncol Rep.
25:383–391. 2011.
|
|
10
|
Liu FY, Zhao ZJ, Li P, Ding X, Zong ZH and
Sun CF: Mammalian target of rapamycin (mTOR) is involved in the
survival of cells mediated by chemokine receptor 7 through PI3K/Akt
in metastatic squamous cell carcinoma of the head and neck. Br J
Oral Maxillofac Surg. 48:291–296. 2010. View Article : Google Scholar
|
|
11
|
Zhao ZJ, Liu FY, Li P, Ding X, Zong ZH and
Sun CF: CCL19-induced chemokine receptor 7 activates the
phosphoinositide-3 kinase-mediated invasive pathway through Cdc42
in metastatic squamous cell carcinoma of the head and neck. Oncol
Rep. 25:729–737. 2011.
|
|
12
|
Wang J, Xi L, Hunt JL, et al: Expression
pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell
carcinoma of the head and neck identifies a novel metastatic
phenotype. Cancer Res. 64:1861–1866. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bardi G, Niggli V and Loetscher P: Rho
kinase is required for CCR7-mediated polarization and chemotaxis of
T lymphocytes. FEBS Lett. 542:79–83. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Riol-Blanco L, Sánchez-Sánchez N, Torres
A, et al: The chemokine receptor CCR7 activates in dendritic cells
two signaling modules that independently regulate chemotaxis and
migratory speed. J Immunol. 174:4070–4080. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cuesta-Mateos C, López-Giral S,
Alfonso-Pérez M, et al: Analysis of migratory and prosurvival
pathways induced by the homeostatic chemokines CCL19 and CCL21 in
B-cell chronic lymphocytic leukemia. Exp Hematol. 38:756.e4–764.e4.
2010. View Article : Google Scholar
|
|
16
|
Bishop AL and Hall A: Rho GTPases and
their effector proteins. Biochem J. 348:241–255. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Riento K and Ridley AJ: Rocks:
multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol.
4:446–456. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ono S: Regulation of actin filament
dynamics by actin depolymerizing factor/cofilin and
actin-interacting protein 1: new blades for twisted filaments.
Biochemistry. 42:13363–13370. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Olson MF: Applications for ROCK kinase
inhibition. Curr Opin Cell Biol. 20:242–248. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Freitas VM, Rangel M, Bisson LF, Jaeger RG
and Machado-Santelli GM: The geodiamolide H, derived from Brazilian
sponge Geodia corticostylifera, regulates actin cytoskeleton,
migration and invasion of breast cancer cells cultured in
three-dimensional environment. J Cell Physiol. 216:583–594. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ren XD and Schwartz MA: Determination of
GTP loading on Rho. Methods Enzymol. 325:264–272. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Muller A, Homey B, Soto H, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pellegrin S and Mellor H: Rho GTPase
activation assays. Current Protocols in Cell Biology. Bonifacino
Juan S, et al: 38. John Wiley & Sons, Inc; Hoboken, NJ: pp.
14.8.1–14.8.19. 2008
|
|
24
|
Wang J, Zhang X, Thomas SM, et al:
Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated
invasive and prosurvival pathways in head and neck cancer cells
independent of EGFR. Oncogene. 24:5897–5904. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang L, Liu F, Xu Z, Guo N, Zheng X and
Sun C: Chemokine receptor 7 via proline-rich tyrosine kinase-2
upregulates the chemotaxis and migration ability of squamous cell
carcinoma of the head and neck. Oncol Rep. 28:1659–1664.
2012.PubMed/NCBI
|
|
26
|
Kakinuma T and Hwang ST: Chemokines,
chemokine receptors, and cancer metastasis. J Leukoc Biol.
79:639–651. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ridley AJ: RhoA, RhoB and RhoC have
different roles in cancer cell migration. J Microsc. 251:242–249.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Etienne-Manneville S and Hall A: Rho
GTPases in cell biology. Nature. 420:629–635. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Routhier A, Astuccio M, Lahey D, et al:
Pharmacological inhibition of Rho-kinase signaling with Y-27632
blocks melanoma tumor growth. Oncol Rep. 23:861–867.
2010.PubMed/NCBI
|
|
30
|
Bernard O: Lim kinases, regulators of
actin dynamics. Int J Biochem Cell Biol. 39:1071–1076. 2007.
View Article : Google Scholar
|
|
31
|
Ghosh M, Song X, Mouneimne G, Sidani M,
Lawrence DS and Condeelis JS: Cofilin promotes actin polymerization
and defines the direction of cell motility. Science. 304:743–746.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rattan R, Giri S, Singh AK and Singh I:
Rho/ROCK pathway as a target of tumor therapy. J Neurosci Res.
83:243–255. 2006. View Article : Google Scholar
|
|
33
|
Shimokawa H and Rashid M: Development of
Rho-kinase inhibitors for cardiovascular medicine. Trends Pharmacol
Sci. 28:296–302. 2007. View Article : Google Scholar : PubMed/NCBI
|
